EUVIMEDEUVIMED entdecken
Open Access

Prevalence of Intersex/Differences in Sex Development and Primary Gonadal Insufficiency in a Pediatric Transgender Population

Hari Randhawa, Michelle M Knoll iD, Michael McPhaul, Kavitha Dileepan, Ryan McDonough, Angela Turpin, Jill D Jacobson

Transgender Health · 01.12.2024 · 9 (6) · 544-552

DOI: 10.1089/trgh.2023.0033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transgender Health, online erschienen am 16.12.2024. Verfasst von Hari Randhawa und 6 weiteren Autor:innen. Beteiligte Einrichtung: University of Missouri-Kansas City School of Medicine, Kansas City, Missouri, USA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study aims to assess the prevalence of intersex variations/differences in sex development (I/DSDs), associated adrenal conditions, and primary gonadal insufficiency in children with gender dysphoria.

Methods

We performed a comprehensive review of the medical records for individuals who carried the diagnostic codes for gender dysphoria in addition to intersex and/or other conditions associated with sex steroid variations among patients evaluated by pediatric endocrinologists from 2013 to 2022.

Results

We found that 9 of 612 (1.5%) transmasculine (TM) and 4 of 215 (1.9%) transfeminine patients had detectable I/DSDs. Although most patients were diagnosed with I/DSDs before evaluation of gender dysphoria, 4 of 13 (30.7%) were diagnosed with I/DSDs after being referred to endocrinology for gender dysphoria. In all cases, diagnoses were made by the endocrinologists evaluating for gender dysphoria. An additional 0.7% of TM patients were diagnosed with distinct hyperandrogenic adrenal conditions, and 1% of TM patients were diagnosed with primary ovarian insufficiency.

Conclusion

The low, but clinically relevant, prevalence of I/DSDs, distinct adrenal conditions, and primary gonadal insufficiency in this transgender population supports the need for access to individualized expert medical care. Specifically, multidisciplinary clinics with experience in endocrinology may provide specialized support for the transgender community.

Schlagwörter

Stichwörter der Autor:innen

congenital adrenal hyperplasiadifferences in sex developmentprimary ovarian insufficiencytransgender femalestransgender males

Autor:innen und Institutionen

  • University of Missouri-Kansas City School of Medicine, Kansas City, Missouri, USA.
  • Division of Endocrinology and Diabetes, Department of Pediatrics, Children's Mercy Kansas City, Kansas City, Missouri, USA.
  • Quest Diagnostics' Nichols Institute, San Juan Capistrano, California, USA.
  • Department of Medical Informatics, Children's Mercy Kansas City, Kansas City, Missouri, USA.

ORCID-Profile: Michelle M Knoll

Zitieren

APA

Randhawa, H., Knoll, M. M., McPhaul, M., Dileepan, K., McDonough, R., Turpin, A., & Jacobson, J. D. (2024). Prevalence of Intersex/Differences in Sex Development and Primary Gonadal Insufficiency in a Pediatric Transgender Population. Transgender Health, 9(6), 544-552. https://doi.org/10.1089/trgh.2023.0033

Vancouver

Randhawa H, Knoll MM, McPhaul M, Dileepan K, McDonough R, Turpin A, et al. Prevalence of Intersex/Differences in Sex Development and Primary Gonadal Insufficiency in a Pediatric Transgender Population. Transgender Health. 2024;9(6):544-552. doi:10.1089/trgh.2023.0033

BibTeX
@article{Randhawa2024,
  author = {Randhawa, Hari and Knoll, Michelle M and McPhaul, Michael and Dileepan, Kavitha and McDonough, Ryan and Turpin, Angela and Jacobson, Jill D},
  title = {Prevalence of Intersex/Differences in Sex Development and Primary Gonadal Insufficiency in a Pediatric Transgender Population},
  journal = {Transgender Health},
  year = {2024},
  volume = {9},
  number = {6},
  pages = {544--552},
  doi = {10.1089/trgh.2023.0033}
}
Kostenlos starten →